Terms: = Germ cell tumor AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Prognosis
20 results:
1. A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.
Liu W; Fu Y; Wang M; Zhao J; Chen J; Wang Y; Qin H
Sci Rep; 2023 Oct; 13(1):17153. PubMed ID: 37821528
[TBL] [Abstract] [Full Text] [Related]
2. [Advances of glioma biomarkers].
Hao M; Liang Y; Guo R; Li X; Li Y; Wang L; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1445-1461. PubMed ID: 37154316
[TBL] [Abstract] [Full Text] [Related]
3. cell Cycle-Related FAM64A Could be Activated by TGF-β Signaling to Promote Glioma Progression.
Fu M; Zhang J; Zhang L; Feng Y; Fang X; Zhang J; Wen W; Hua W; Mao Y
Cell Mol Neurobiol; 2023 Aug; 43(6):2975-2987. PubMed ID: 37081231
[TBL] [Abstract] [Full Text] [Related]
4. SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation.
Yi X; Wang H; Yang Y; Wang H; Zhang H; Guo S; Chen J; Du J; Tian Y; Ma J; Zhang B; Wu L; Shi Q; Gao T; Guo W; Li C
Signal Transduct Target Ther; 2023 Mar; 8(1):107. PubMed ID: 36918544
[TBL] [Abstract] [Full Text] [Related]
5. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
Feng F; Zhao Z; Cai X; Heng X; Ma X
Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
[TBL] [Abstract] [Full Text] [Related]
6. Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.
Georgescu MM; Islam MZ; Li Y; Circu ML; Traylor J; Notarianni CM; Kline CN; Burns DK
Acta Neuropathol Commun; 2020 Jul; 8(1):111. PubMed ID: 32680567
[TBL] [Abstract] [Full Text] [Related]
7. Growth-Inhibitory Activity of Bone Morphogenetic Protein 4 in Human Glioblastoma cell Lines Is Heterogeneous and Dependent on Reduced SOX2 Expression.
Dalmo E; Johansson P; Niklasson M; Gustavsson I; Nelander S; Westermark B
Mol Cancer Res; 2020 Jul; 18(7):981-991. PubMed ID: 32234828
[TBL] [Abstract] [Full Text] [Related]
8. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
[TBL] [Abstract] [Full Text] [Related]
9. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
Park HY; Kwon MJ; Kang HS; Kim YJ; Kim NY; Kim MJ; Min KW; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Lee HK
Hum Pathol; 2019 May; 87():83-94. PubMed ID: 30851333
[TBL] [Abstract] [Full Text] [Related]
10. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.
Simbolo M; Vicentini C; Mafficini A; Fassan M; Pedron S; Corbo V; Mastracci L; Rusev B; Pedrazzani C; Landoni L; Grillo F; Cingarlini S; Rindi G; Luchini C; Scarpa A; Lawlor RT
Virchows Arch; 2018 Dec; 473(6):709-717. PubMed ID: 30219970
[TBL] [Abstract] [Full Text] [Related]
11. Predictive genetic profiles for regional lymph node metastasis in primary cutaneous melanoma: a case-matched pilot study.
Nye A; Collins JD; Porter CL; Montes de Oca M; George K; Stafford CG; Schammel CMG; Horton S; Trocha SD
Melanoma Res; 2018 Dec; 28(6):555-561. PubMed ID: 30179987
[TBL] [Abstract] [Full Text] [Related]
12. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract] [Full Text] [Related]
13. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract] [Full Text] [Related]
14. Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.
Vollbrecht C; Werner R; Walter RF; Christoph DC; Heukamp LC; Peifer M; Hirsch B; Burbat L; Mairinger T; Schmid KW; Wohlschlaeger J; Mairinger FD
Br J Cancer; 2015 Dec; 113(12):1704-11. PubMed ID: 26645239
[TBL] [Abstract] [Full Text] [Related]
15. Overexpression of the BMP4/SMAD signaling pathway in skull base chordomas is associated with poor prognosis.
Feng Y; Zhang Q; Wang Z; Yan B; Wei W; Li P
Int J Clin Exp Pathol; 2015; 8(7):8268-75. PubMed ID: 26339396
[TBL] [Abstract] [Full Text] [Related]
16. Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.
Jung Y; Park H; Zhao HY; Jeon R; Ryu JH; Kim WY
Mol Cells; 2014 Jul; 37(7):547-53. PubMed ID: 25078449
[TBL] [Abstract] [Full Text] [Related]
17. Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.
Kim JH; Kang GH
World J Gastroenterol; 2014 Apr; 20(15):4230-43. PubMed ID: 24764661
[TBL] [Abstract] [Full Text] [Related]
18. Molecular pathology and genetics of pancreatic endocrine tumours.
Capurso G; Festa S; Valente R; Piciucchi M; Panzuto F; Jensen RT; Delle Fave G
J Mol Endocrinol; 2012 Aug; 49(1):R37-50. PubMed ID: 22586144
[TBL] [Abstract] [Full Text] [Related]
19. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
Yachida S; Vakiani E; White CM; Zhong Y; Saunders T; Morgan R; de Wilde RF; Maitra A; Hicks J; Demarzo AM; Shi C; Sharma R; Laheru D; Edil BH; Wolfgang CL; Schulick RD; Hruban RH; Tang LH; Klimstra DS; Iacobuzio-Donahue CA
Am J Surg Pathol; 2012 Feb; 36(2):173-84. PubMed ID: 22251937
[TBL] [Abstract] [Full Text] [Related]
20. Reduced expression of smad4 in gliomas correlates with progression and survival of patients.
He SM; Zhao ZW; Wang Y; Zhao JP; Wang L; Hou F; Gao GD
J Exp Clin Cancer Res; 2011 Jul; 30(1):70. PubMed ID: 21791112
[TBL] [Abstract] [Full Text] [Related]
